[Differential indication for the use of neuroleptics].
D000082:Acetaminophen / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D004357:Drug Synergism; D005476:Fluphenazine / Q000627:therapeutic use; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008722:Methods; D010259:Paranoid Disorders / Q000188:drug therapy; D010919:Placebos; D011346:Prochlorperazine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D012959:Socioeconomic Factors; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010919:Placebos; D014149:Tranquilizing Agents; D000082:Acetaminophen; D013881:Thioridazine; D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine; D011346:Prochlorperazine
Diferenciální indikace neuroleptik.